FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule


Advisory Committees

Nature and Basis Statements of Conflict(s) of Interest for Voting Members of FDA Advisory Committee Members

The Food and Drug Administration Amendments Act of 2007 (FDAAA), enacted on September 27, 2007, added a new provision regarding financial conflicts of interest, § 712 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), effective October 1, 2007. Accordingly, for advisory committee meetings after October 1, 2007, FDA is granting waivers under 18 U.S.C. § 208 and § 712 of the FD&C Act, where applicable, when the relevant waiver standards in these statutes are met.

Waivers under 21 U.S.C. § 355(n)(4) were issued before October 1, 2007.  This provision was repealed, effective October 1, 2007, by the FDAAA.

Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee

October 18-19, 2007

Ralph D’Agostino, Ph.D.

  • 18 U.S.C. 208 waiver (pdf)
  • Acknowledgement and Consent (pdf)
  • 712 (c) (2) (B) waiver (pdf) (updated 10/17/07)
  • Acknowledgement of 712 (c) (2) (B) waiver (pdf) (updated 10/18/07)

Page updated: October 18, 2007